“…9,10 Thus, the need for novel and more effective treatment regimens for neuroblastoma is imperative. [11][12][13] One of the novel therapeutic approaches under active investigation to improve outcomes is iodine-131 meta-iodobenzylguanidine ( 131 I-mIBG). mIBG is an analog of the catecholamine norepinephrine, which can be labeled with a radioactive isotope, 131 I, to use clinically for treatment.…”